Filing Details

Accession Number:
0001415889-24-009046
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-03-25 17:41:42
Reporting Period:
2024-03-25
Accepted Time:
2024-03-25 17:41:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1759425 Mirum Pharmaceuticals Inc. MIRM () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1650131 Peter Radovich C/O Mirum Pharmaceuticals, Inc.
950 Tower Lane, Suite 1050
Foster City CA 94404
President And Coo No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-03-25 4,303 $25.80 29,013 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The weighted average sale price for the transaction reported was $25.80, and the range of prices were between $25.80 and $25.825. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.